Sodium (3aR,4R,6R,6aR)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-6-(hydroxymethyl)tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-2-olate 2-oxide(CAS: 15718-49-7)

This compound is a crystalline solid with a molecular weight of approximately 538.34 g/mol. It has low solubility in water but is soluble in organic solvents. It is reactive towards bases and can form complexes with metal ions. The compound is stable under normal laboratory conditions but should be stored in a well-ventilated area to prevent exposure to moisture and air.

The synthesis of this compound involves multi-step organic reactions such as nucleophilic substitution and condensation. It typically requires the use of Lewis acids and bases as catalysts. The yield and selectivity depend on the reaction conditions and the choice of reagents. Detailed procedures for synthesis can be found in the literature and are often reported in academic journals.

This compound is primarily used in pharmaceutical applications, particularly in the development of antiviral drugs. It may also have potential uses in polymer chemistry and as a sensor material due to its unique chemical properties. However, its specific applications are limited due to its complex structure and the challenges associated with its synthesis and handling.

When handling this compound, it is essential to use personal protective equipment (PPE) such as gloves and safety goggles. Work should be conducted in a well-ventilated area or a fume hood to prevent inhalation of airborne particles. Spills should be cleaned up using appropriate absorbents, and the area should be thoroughly rinsed with water. Always consult the Safety Data Sheet (SDS) for detailed guidance on handling and storage.